Kivexa 300 mg (Lamivudine TABLET) 300 MG

KIVEXA 300 MG tablets contain lamivudine, an antiretroviral medication used to manage HIV. This oral treatment is part of combination therapy to control the virus.

Strength

300 MG

Pack Size

Manufacturer / TM Owner

VIIV HEALTHCARE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KIVEXA 300 MG tablets are primarily used in the treatment of HIV infection. Lamivudine, the active ingredient, works by inhibiting the virus's ability to replicate. This medication is typically prescribed as part of a broader antiretroviral therapy regimen to help manage HIV and improve immune function. What is KIVEXA 300 MG used for? It is used to control HIV infection in combination with other antiretroviral drugs.

Side Effects

Common effects of KIVEXA 300 MG tablets may include headaches, nausea, and fatigue. Some individuals might experience dizziness or insomnia. These effects vary and are not experienced by everyone. If any effects are severe or persistent, it is important to consult a healthcare provider.

Precautions & Warnings

KIVEXA 300 MG tablets should be handled with care. Store them at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Always follow the prescribed dosage and instructions provided by your healthcare provider. Do not share this medication with others.

Avoid Interactions

KIVEXA 300 MG tablets may interact with other medications, including certain antiretrovirals and drugs that affect the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the treatment.

Frequently Asked Questions

KIVEXA 300 MG tablets are used in combination with other antiretroviral drugs to manage HIV infection.

KIVEXA 300 MG tablets are taken orally, typically once or twice daily as prescribed by a healthcare provider.

Common side effects may include headaches, nausea, fatigue, dizziness, and insomnia.

Consult your healthcare provider before consuming alcohol while taking KIVEXA 300 MG tablets.

Store KIVEXA 300 MG tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.